Zobrazeno 1 - 10
of 17
pro vyhledávání: '"William M. Schultz"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
IntroductionPazopanib is a tyrosine kinase inhibitor approved for the treatment of metastatic renal cell carcinoma and advanced soft-tissue sarcoma that functions by inhibiting vascular endothelial growth factor receptors. Although the package insert
Externí odkaz:
https://doaj.org/article/c05e03b8483c473db36d0b42ef9e08bb
Autor:
William M. Schultz, Salim S. Hayek, Ayman Samman Tahhan, Yi‐An Ko, Pratik Sandesara, Mosaab Awad, Kareem H. Mohammed, Keyur Patel, Michael Yuan, Shuai Zheng, Matthew L. Topel, Joy Hartsfield, Ravila Bhimani, Tina Varghese, Jonathan H. Kim, Leslee Shaw, Peter Wilson, Viola Vaccarino, Arshed A. Quyyumi
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 12 (2017)
BackgroundBeing unmarried is associated with decreased survival in the general population. Whether married, divorced, separated, widowed, or never‐married status affects outcomes in patients with cardiovascular disease has not been well characteriz
Externí odkaz:
https://doaj.org/article/4dea50332efa428ea3efab2ad232dce0
Autor:
Danny J. Eapen, William M. Schultz, Robert E. Heinl, Nima Ghasemzadeh, Tina Varghese, Diana E. Kurian, Christina E. Mathai, Pratik Sandesara, Bryan R. Kindya, Marc P. Allard-Ratick, Neal K. Bhatia, Ijeoma Isiadinso, Laurence Sperling
Publikováno v:
Cardiovascular Innovations and Applications, Vol 1, Iss 4, p 379 (2016)
Cardiovascular disease (CVD) is the leading cause of death worldwide. This article focuses on current guidelines for the primary prevention of CVD and addresses management of key risk factors. Dietary modification, weight loss, exercise, and tobacco
Externí odkaz:
https://doaj.org/article/cbc5585bb19342b987426786fb649733
Autor:
Ayman Samman Tahhan, Arshed A. Quyyumi, William M. Schultz, Devinder S. Dhindsa, Jay Khambhati
Publikováno v:
Trends in Cardiovascular Medicine. 30:215-220
The national burden of cardiovascular disease (CVD) continues to impose significant risk of morbidity, mortality and increased costs. While traditional risk factors have been well-established, the evolving role of non-traditional risk factors, includ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b187d1e07519fa3df807a848825edc5
https://doi.org/10.1016/j.tcm.2019.05.012
https://doi.org/10.1016/j.tcm.2019.05.012
Autor:
Devinder S. Dhindsa, Danny J. Eapen, Laurence S. Sperling, Robert E. Heinl, Elliot N. Mahlof, William M. Schultz, Pratik B. Sandesara, Hannah C. Cai, Tina Varghese
Publikováno v:
Cardiovascular Endocrinology. 6:128-135
Type 2 diabetes mellitus (DM) is a significant cause of premature complications and mortality in patients with cardiovascular disease (CVD). In addition to lifestyle modifications, conventional treatment of DM consists of oral hypoglycemic agents, in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ef67b22dae9ee46c6a47a0cd397358
https://doi.org/10.1097/xce.0000000000000134
https://doi.org/10.1097/xce.0000000000000134
Autor:
Laurence S. Sperling, Heval M. Kelli, Marc Allard-Ratick, William M. Schultz, Danny J. Eapen, Tina Varghese, Amirhossein Esmaeeli, Robert E. Heinl, Pratik B. Sandesara, Johnathan C. Ricketts, Devinder S. Dhindsa, Anthony J. Millard, Elliot N. Mahlof
Publikováno v:
Canadian Journal of Cardiology. 32:S349-S357
The epidemic of obesity has contributed to a growing burden of metabolic syndrome (MetS) and diabetes mellitus (DM) worldwide. MetS is defined as central obesity along with associated factors such as hypertriglyceridemia, low high-density lipoprotein
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36315c1619a9e130391e9e3c6c46b070
https://doi.org/10.1016/j.cjca.2016.07.507
https://doi.org/10.1016/j.cjca.2016.07.507
Autor:
Keith C. Ferdinand, Pratik B. Sandesara, Jennifer H. Mieres, Laurence S. Sperling, George A. Mensah, Heval M. Kelli, William M. Schultz, John Gordon Harold, Jia Shen, Herman A. Taylor, Martha Gulati, John Lisko, Arshed A. Quyyumi, Tina Varghese
Publikováno v:
Circulation, vol 137, iss 20
Socioeconomic status (SES) has a measurable and significant effect on cardiovascular health. Biological, behavioral, and psychosocial risk factors prevalent in disadvantaged individuals accentuate the link between SES and cardiovascular disease (CVD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1e05077dc09fa743a976492a98be5d5
https://pubmed.ncbi.nlm.nih.gov/29760227
https://pubmed.ncbi.nlm.nih.gov/29760227
Autor:
Peter W.F. Wilson, Leslee J. Shaw, Keyur Patel, Ravila Bhimani, Kareem Hosny Mohammed, Shuai Zheng, Viola Vaccarino, Pratik B. Sandesara, Michael Yuan, Yi-An Ko, Ayman Samman Tahhan, Tina Varghese, Arshed A. Quyyumi, Joy Hartsfield, Mosaab Awad, Jonathan H. Kim, William M. Schultz, Matthew L. Topel, Salim S. Hayek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Being unmarried is associated with decreased survival in the general population. Whether married, divorced, separated, widowed, or never‐married status affects outcomes in patients with cardiovascular disease has not been well characteri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a50138c8462aa29db792e71c715422e
http://europepmc.org/articles/PMC5778993
http://europepmc.org/articles/PMC5778993
Publikováno v:
Current pharmaceutical design. 22(25)
Background: Psychosocial risk factors such as stress and psychiatric disorders are known to have negative impacts on health outcomes, but their effects on ischemic heart disease, particularly in women, remain to be fully understood despite contributi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d649c3dd3d976038043beceec20318ef
https://pubmed.ncbi.nlm.nih.gov/27194439
https://pubmed.ncbi.nlm.nih.gov/27194439
Autor:
Anita A. Kelkar, Faisal Khosa, Arshed A. Quyyumi, Daniel S. Berman, Matthew J. Budoff, Tracy Q. Callister, Briain O’Hartaigh, Heidi Gransar, Joshua Schulman-Marcus, Joseph T. Knapper, Michael J. Blaha, William M. Schultz, James K. Min, Leslee J. Shaw
Publikováno v:
Circulation. Cardiovascular imaging, vol 9, iss 4
Kelkar, AA; Schultz, WM; Khosa, F; Schulman-Marcus, J; O'Hartaigh, BWJ; Gransar, H; et al.(2016). Long-Term Prognosis After Coronary Artery Calcium Scoring Among Low-Intermediate Risk Women and Men. CIRCULATION-CARDIOVASCULAR IMAGING, 9(4), e003742. doi: 10.1161/CIRCIMAGING.115.003742. UCLA: Retrieved from: http://www.escholarship.org/uc/item/91g4t31b
Kelkar, AA; Schultz, WM; Khosa, F; Schulman-Marcus, J; O'Hartaigh, BWJ; Gransar, H; et al.(2016). Long-Term Prognosis After Coronary Artery Calcium Scoring Among Low-Intermediate Risk Women and Men. CIRCULATION-CARDIOVASCULAR IMAGING, 9(4), e003742. doi: 10.1161/CIRCIMAGING.115.003742. UCLA: Retrieved from: http://www.escholarship.org/uc/item/91g4t31b
Background— Cardiovascular screening of women using traditional risk factors has been challenging, with results often classifying a majority of women as lower risk than men. The aim of this report was to determine the long-term prognosis of asympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61310afe8c8285d8f33289bb1085665c
https://escholarship.org/uc/item/91g4t31b
https://escholarship.org/uc/item/91g4t31b
